Buy or sell HeartFlow stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

HeartFlow Stock

Software for cardiovascular applications

Founded

2007

Notable Investors

Baillie Gifford

Headquarters

Redwood City CA, US

Total Funding

$564M

About HeartFlow Stock

HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease. It offers HeartFlow Analysis, a non-invasive solution available in the United States, Europe, and Japan that helps a physician evaluate whether a patient has significant coronary artery disease based on anatomy and physiology. Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 that became HeartFlow in May 2009. Its headquarters is in Redwood City in California.

Investors

Capricorn Investment Group

HeartFlow, Innovium

Martis Capital

HeartFlow

Panorama Point Partners

HeartFlow, Addepar, Porch

Rancilio Cube

HeartFlow, Taboola

Wellington Management

HeartFlow, Away, Omada Health

Funding History

July 2009$2.0M
August 2010$6.9M
August 2010$10.1M
December 2011$105M
January 2015$99.9M
November 2017$340M

Management

Chief Executive Officer & President

Dana Mead

Co-Founder & Senior Vice President of Medical Affairs

Christopher K. Zarins

Co-Founder & Chief Technology Officer

Charles A. Taylor

Chief Financial Officer

Baird Radford

Chief Medical Officer

Campbell Rogers

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from HeartFlow or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo